Syndrome of a systemic inflammatory reaction at the acute pancreatitis: peculiarities of a molecular pathophysiology and possible ways of correction

被引:0
作者
Gorsky, V. A. [1 ]
Agapov, M. A. [1 ]
Kovalchuk, L. V. [2 ]
Ovanesyan, E. R. [1 ]
Khoreva, M. V. [2 ]
Nickonova, A. S. [2 ]
Leonenko, I. V. [3 ]
Indarockov, V. A. [1 ]
Grechenko, V. V. [2 ]
机构
[1] NI Pirogov Russian State Med Univ, Medicobiol Fac Surg Chair, Moscow, Russia
[2] NI Pirogov Russian State Med Univ, Medicobiol Fac Immunol Chair, Moscow, Russia
[3] NI Pirogov Russian State Med Univ, Medicobiol Fac Chair, Moscow, Russia
关键词
acute pancreatitis; syndrome of a systemic inflammatory reaction; cytokines;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim of the given work is a study of the lornoxycam-cyclooxygenase inhibitor influence on the proinflammatory and antiinflammatory cytokine output, stipulated by ligands of the 1st and 2nd type Toll-like receptors (TLR1/2) and the 4th type Toll-like receptors (TLR4), the mononuclear cells of the healthy donor peripheral blood in vitro and in patients with the AP. Materials and methods. Influence of a nonsteroid antiinflammatory preparation on a synthesis of the pro- and and antiinflammatory cytokines was assessed in 10 healthy donors and 11 patients with the acute pancreatitis. Results. A release of the endogenous ligand significant concentrations takes place at the acute pancreatitis as a result of the organism proper cell large number death, which leads to activation of the TLR signal ways, activation of the immune system cell and starts the pro-inflammatory cytokine output. That fact necessitates the preparation with a cytokine-inhibiting activity inclusion into a complex therapy of AP.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 14 条
  • [1] Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients
    Abraham, E
    Laterre, PF
    Garbino, J
    Pingleton, S
    Butler, T
    Dugernier, T
    Margolis, B
    Kudsk, K
    Zimmerli, W
    Anderson, P
    Reynaert, M
    Lew, D
    Lesslauer, W
    Passe, S
    Cooper, P
    Burdeska, A
    Modi, M
    Leighton, A
    Salgo, M
    Van der Auwera, P
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (03) : 503 - 510
  • [2] Bhatia M, 2000, J PATHOL, V190, P117
  • [3] DAMPs, PAMPs and alarmins: all we need to know about danger
    Bianchi, Marco E.
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 81 (01) : 1 - 5
  • [4] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [5] Proinflammatory effects of pancreatic elastase are mediated through TLR4 and NF-κB
    Hietaranta, A
    Mustonen, H
    Puolakkainen, P
    Haapiainen, R
    Kemppainen, E
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 323 (01) : 192 - 196
  • [6] Li Hong-Guang, DIGESTIVE DIS SCI
  • [7] Toll-like receptors and innate immunity
    Medzhitov, R
    [J]. NATURE REVIEWS IMMUNOLOGY, 2001, 1 (02) : 135 - 145
  • [8] EVOLVING CONCEPTS IN THE PATHOGENESIS OF POSTINJURY MULTIPLE ORGAN FAILURE
    MOORE, FA
    MOORE, EE
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 1995, 75 (02) : 257 - 277
  • [9] The role of TLR activation in inflammation
    Sabroe, I.
    Parker, L. C.
    Dower, S. K.
    Whyte, M. K. B.
    [J]. JOURNAL OF PATHOLOGY, 2008, 214 (02) : 126 - 135
  • [10] Toll-like receptors
    Takeda, K
    Kaisho, T
    Akira, S
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 : 335 - 376